RESUMO
Children with chronic kidney disease (CKD) are at risk for vitamin deficiency or excess. Vitamin status can be affected by diet, supplements, kidney function, medications, and dialysis. Little is known about vitamin requirements in CKD, leading to practice variation.The Pediatric Renal Nutrition Taskforce (PRNT), an international team of pediatric kidney dietitians and pediatric nephrologists, was established to develop evidence-based clinical practice points (CPPs) to address challenges and to serve as a resource for nutritional care. Questions were formulated using PICO (Patient, Intervention, Comparator, Outcomes), and literature searches undertaken to explore clinical practice from assessment to management of vitamin status in children with CKD stages 2-5, on dialysis and post-transplantation (CKD2-5D&T). The CPPs were developed and finalized using a Delphi consensus approach. We present six CPPs for vitamin management for children with CKD2-5D&T. We address assessment, intervention, and monitoring. We recommend avoiding supplementation of vitamin A and suggest water-soluble vitamin supplementation for those on dialysis. In the absence of evidence, a consistent structured approach to vitamin management that considers assessment and monitoring from dietary, physical, and biochemical viewpoints is needed. Careful consideration of the impact of accumulation, losses, comorbidities, and medications needs to be explored for the individual child and vitamin before supplementation can be considered. When supplementing, care needs to be taken not to over-prescribe. Research recommendations are suggested.
RESUMO
Obesity and metabolic syndrome (O&MS) due to the worldwide obesity epidemic affects children at all stages of chronic kidney disease (CKD) including dialysis and after kidney transplantation. The presence of O&MS in the pediatric CKD population may augment the already increased cardiovascular risk and contribute to the loss of kidney function. The Pediatric Renal Nutrition Taskforce (PRNT) is an international team of pediatric renal dietitians and pediatric nephrologists who develop clinical practice recommendations (CPRs) for the nutritional management of children with kidney diseases. We present CPRs for the assessment and management of O&MS in children with CKD stages 2-5, on dialysis and after kidney transplantation. We address the risk factors and diagnostic criteria for O&MS and discuss their management focusing on non-pharmacological treatment management, including diet, physical activity, and behavior modification in the context of age and CKD stage. The statements have been graded using the American Academy of Pediatrics grading matrix. Statements with a low grade or those that are opinion-based must be carefully considered and adapted to individual patient needs based on the clinical judgment of the treating physician and dietitian. Research recommendations are provided. The CPRs will be periodically audited and updated by the PRNT.
Assuntos
Síndrome Metabólica , Obesidade Infantil , Insuficiência Renal Crônica , Criança , Humanos , Transplante de Rim , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/terapia , Obesidade Infantil/diagnóstico , Obesidade Infantil/terapia , Guias de Prática Clínica como Assunto , Diálise Renal , Insuficiência Renal Crônica/epidemiologia , Insuficiência Renal Crônica/terapiaAssuntos
Anticorpos Monoclonais Humanizados/economia , Síndrome Hemolítico-Urêmica Atípica/economia , Síndrome Hemolítico-Urêmica Atípica/terapia , Países em Desenvolvimento/economia , Troca Plasmática/economia , Anticorpos Monoclonais Humanizados/uso terapêutico , Humanos , Lactente , Recém-Nascido , Mutação , Pobreza/economiaRESUMO
BACKGROUND: Patients are becoming increasingly involved in research which can promote innovation through novel ideas, support patient-centred actions, and facilitate drug development. For rare diseases, registries that collect data from patients can increase knowledge of the disease's natural history, evaluate clinical therapies, monitor drug safety, and measure quality of care. The active participation of patients is expected to optimise rare-disease management and improve patient outcomes. However, few reports address the type and frequency of interactions involving patients, and what research input patient groups have. Here, we describe a collaboration between an international group of patient organisations advocating for patients with atypical haemolytic uraemic syndrome (aHUS), the aHUS Alliance, and an international aHUS patient registry (ClinicalTrials.gov NCT01522183). RESULTS: The aHUS Registry Scientific Advisory Board (SAB) invited the aHUS Alliance to submit research ideas important to patients with aHUS. This resulted in 24 research suggestions from patients and patient organisations being presented to the SAB. The proposals were classified under seven categories, the most popular of which were understanding factors that cause disease manifestations and learning more about the clinical and psychological/social impact of living with the disease. Subsequently, aHUS Alliance members voted for up to five research priorities. The top priority was: "What are the outcomes of a transplant without eculizumab and what non-kidney damage is likely in patients with aHUS?". This led directly to the initiation of an ongoing analysis of the data collected in the Registry on patients with kidney transplants. CONCLUSION: This collaboration resulted in several topics proposed by the aHUS Alliance being selected as priority activities for the aHUS Registry, with one new analysis already underway. A clear pathway was established for engagement between a patient advocacy group and an international research network. This should ensure the development of a long-term partnership which clearly benefits both groups.
Assuntos
Síndrome Hemolítico-Urêmica Atípica , Comportamento Cooperativo , Setor de Assistência à Saúde/organização & administração , Doenças Raras , Sistema de Registros , HumanosRESUMO
BACKGROUND: Hemodialysis (HD) in children with a concomitant ventriculoperitoneal shunt (VPS) is rare. Registry data suggest that peritoneal dialysis with a VPS is safe, but little is known about HD in the presence of a VPS. METHODS: We performed a 10-year survey to determine the prevalence of a VPS, complications and outcome in children with a VPS on HD in 15 dialysis units from the 13 countries participating in the European Pediatric Dialysis Working Group. RESULTS: Eleven cases of HD with a VPS were reported (prevalence 1.33 %; 328 patient-months) and compared with prospective Registry data. The median age at start of dialysis was 9.6 [inter-quartile range (IQR) 1.0-15.0] years and median HD vintage was 2.4 (IQR 1.7-3.0) years. Dialysis was performed through a central venous line (CVL) and through an arteriovenous fistula in six and five children, respectively. Three CVL infections occurred in two children, but these children did not develop VPS infections or meningitis. Symptoms of hemodynamic instability were reported in six (55 %) children at least once per week, with hypotension or hypertension occurring in four of these children and nausea, vomiting and headaches occurring in two; four other children reported less frequent symptoms. Seizures on dialysis occurred in two children, at a frequency of less than once per month, with one child also experiencing visual disturbances. During follow-up (median 4.0; IQR 0.38-7.63 years), three children remained on HD and eight had a functioning transplant. No patients were switched to PD. CONCLUSIONS: Hemodialysis in children with a VPS is safe, but associated with frequent symptoms of hemodynamic instability. No episodes of VPS infection or meningitis were seen among the children in the survey, not even in those with CVL sepsis.
Assuntos
Derivação Arteriovenosa Cirúrgica/efeitos adversos , Cateterismo Venoso Central/efeitos adversos , Diálise Renal/efeitos adversos , Insuficiência Renal Crônica/terapia , Derivação Ventriculoperitoneal/efeitos adversos , Adolescente , Fatores Etários , Infecções Relacionadas a Cateter/diagnóstico , Infecções Relacionadas a Cateter/microbiologia , Cateterismo Venoso Central/instrumentação , Cateteres de Demora/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Criança , Pré-Escolar , Europa (Continente) , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Hipertensão/diagnóstico , Hipertensão/etiologia , Hipotensão/diagnóstico , Hipotensão/etiologia , Lactente , Transplante de Rim , Masculino , Insuficiência Renal Crônica/diagnóstico , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Convulsões/diagnóstico , Convulsões/etiologia , Inquéritos e Questionários , Fatores de Tempo , Resultado do Tratamento , Derivação Ventriculoperitoneal/instrumentaçãoRESUMO
PURPOSE: We examine the internalizing problems (anxiety and depression) and self-esteem among 9 to 12-year old children with enuresis to determine whether enuretic children are more in the clinical range, and to study the correlation between child and parent report questionnaires. MATERIALS AND METHODS: A total of 84 children with daytime and/or nighttime wetting were compared to 70 without enuresis using 5 psychometric instruments adjusted for gender and type of enuresis. Differences in mean scores, percentages of children beyond the clinical range, and correlations between child and parent report questionnaires were evaluated. RESULTS: Parental report revealed more internalizing problems ("withdrawn" and "anxious/ depressive") for children with enuresis compared to controls. A higher percentage of the study group were in the clinical range of the "total problem" scale of the Child Behavior Checklist. Child report inventories yielded no differences between groups. Moderate agreement was found between child and parent report. CONCLUSIONS: There is no evidence of internalizing problems (anxiety/depression) and low self-esteem in the self-report of enuretic children. In contrast parents rate enuretic children as having more internalizing problems. Different explanations for this contradictory data are offered. Further research is necessary to explain why parents report psychological symptoms in children with enuresis.